GSK

GlaxoSmithKline and J&J back a $100M new Alzheimer's R&D project
Fierce Biotech
Tue, 03/17/15 - 09:53 am
GSK
JNJ
R&D
Alzheimer's disease
Ebola booster vaccine trial to combine GSK, Emergent Bio shots
Yahoo/Reuters
Mon, 03/16/15 - 09:19 am
ebola virus
vaccines
GSK
Emergent BioSolutions
Johnson & Johnson sues Glaxo over allergy ads as spring nears
Yahoo/Reuters
Thu, 03/12/15 - 09:50 pm
JNJ
GSK
Flonase
Benedryl
Zyrtec
Glaxo to reap $890M as it halves stake in South Africa's Aspen
Fierce Biotech
Thu, 03/12/15 - 09:37 pm
GSK
Aspen
South Africa
GlaxoSmithKline's big bet on electroceuticals
CNBC
Wed, 03/11/15 - 07:53 pm
GSK
electroceuticals
Glaxo plants a flag in Singapore with CEO Witty on hand
Fierce Biotech
Wed, 03/11/15 - 03:14 pm
GSK
Singapore
Andrew Witty
The Fallout Continues: Glaxo Fires Employees in China for Misconduct
WSJ Pharmalot
Fri, 03/6/15 - 03:06 pm
GSK
China
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal To Restructure
Bidness Etc.
Mon, 03/2/15 - 08:11 am
Novartis
GSK
M&A
vaccines
oncology
Glaxo CEO Gets a Haircut: His Pay Package Drops 46% Amid Struggles
WSJ Pharmalot
Thu, 02/26/15 - 04:44 pm
GSK
Andrew Witty
executive pay
GlaxoSmithKline's new chairman will climb aboard months earlier than expected
Fierce Pharma
Thu, 02/26/15 - 03:03 pm
GSK
Philip Hampton
GSK to be No. 1 vaccine producer when it completes $25B asset swap with Novartis next week
Bizjournals.com
Wed, 02/25/15 - 04:39 pm
GSK
Novartis
vaccines
Novartis AG wins approval to buy GSK cancer drugs with conditions
Yahoo/Reuters
Mon, 02/23/15 - 06:00 pm
Novartis
GSK
cancer
BRAF inhibitor
MEK inhibitor
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
M&A
Actavis
Allergan
Forest Labs
GSK
Novartis
Bayer
Merck
Cubist Pharma
Roche
InterMune
Mylan Labs
Abbott Labs
Questcor
Mallinckrodt
Eli Lilly
Sun Pharma
Ranbaxy
Glaxo Names Bailey to Replace Connelly Atop Ailing U.S. Unit
Bloomberg
Mon, 02/16/15 - 04:55 pm
GSK
Deirdre Connelly
Jack Bailey
restructuring
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Motley Fool
Mon, 02/16/15 - 10:19 am
Pfizer
Hospira
M&A
Teva Pharmaceutical
AbbVie
Bristol-Myers Squibb
Abbott Labs
Mylan
GSK
Glaxo CEO says new lung meds are grabbing market share. Yes, really.
Fierce Pharma Marketing
Thu, 02/12/15 - 09:04 am
GSK
Advair
Breo Ellipta
Anoro Ellipta
Andrew Witty
GSK launches Flonase OTC
Medical Marketing and Media
Wed, 02/11/15 - 05:43 pm
GSK
Flonase
OTC
Glaxo Tries To Turn A Triple Play
Seeking Alpha
Wed, 02/11/15 - 09:11 am
GSK
COPD
Chiesi
AstraZeneca
Novartis
Biogen Idec
Ahead of Novartis deal, GlaxoSmithKline scoops up vaccine developer in $190M buyout
Fierce Biotech
Wed, 02/11/15 - 08:00 am
GSK
Novartis
vaccines
M&A
GlycoVaxyn

Pages